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Sloughing esophagitis, also currently known as esophagitis dissecans superficialis, is a degenerative disease of the
squamous epithelium characterized by superficial epithelial necrosis with parakeratosis, but without inflammation,
and detachment of the superficial necrotic zone from the deep viable zone. This leads to a spectacular endoscopic
appearance of sloughed mucosa in streaks and patches. The cause is unknown, and the clinical characteristics
are variable, ranging from incidentally findings to esophageal symptoms. The disease seems to be self-limited, as
resolution of the changes was observed in the few cases for which follow-up endoscopic examinations have been
reported.
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Background and histology
The term “esophagitis dissecans superficialis” (EDS)
was initially described over one century ago by
Rosenberg,1 whereas the name “sloughing eso-
phagitis” was coined by Audrey Lazenby, a gastroin-
testinal pathologist from the University of Alabama
Medical Center. This term initially appeared in
two poster presentations. The first described four
patients at a meeting of the United States and
Canadian Academy of Pathology in 1999, and the
second, which expanded the case number to 32, was
presented at Digestive Disease Week in 2005.2,3 The
patients in these presentations were mostly middle-
aged men who tended to be debilitated, and approxi-
mately half were immunosuppressed. The histologic
changes in esophageal biopsies were impressive.4 At
low magnification, the squamous epithelium has
a two-toned appearance (Fig. 1). The superficial
squamous cell layer, about four to five cells thick,
is necrotic and parakeratotic, with dark red cyto-
plasm and pyknotic nuclei. In contrast, the lower
squamous cells, including the basal and parabasal
layers, have cytoplasm and nuclei that appear nor-
mal. This layer is viable. The superficial necrotic
layer is commonly separated from the deep viable
layer. In other words, it is sloughed, leading to the
name of the condition and to the remarkable endo-
scopic appearances of sloughed mucosa (Fig. 2). A
thin layer of purulent exudate may exist at the point
of separation; however, the process does not seem
to have a predictable inflammatory component. In
a few cases, bacteria are adherent to the necrotic
zone, generally on the undersurface of the sloughed
epithelium.4 There have been a few suggestions as
to why this impressive histologic change occurs,
including that it is a form of contact allergy or a
primary abnormality of cell adhesion molecules,
but currently there is no definitive explanation.
In one controlled study of 31 patients, similar to
the original descriptions by Moore and colleagues,
the patients tended to be debilitated, although in
later descriptions patients with sloughing esophagi-
tis appeared to only have minor medical conditions,
and, in some cases, sloughing esophagitis was found
incidentally.4
Definition
Is sloughing esophagitis the same as the esophageal
disease called EDS? In some older reports of
this condition, the epithelial necrosis was full
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Figure 1. In the typical two-toned microscopic appearance, the necrotic superficial squamous layers have dark red cytoplasm and
pyknotic or parakeratotic nuclei, while the viable lower layers have paler cytoplasm and normal open nuclei (H&E ×100). From
Ref. 20.
thickness and there were chronic forms reported
with stricture.5,6 Both of these features are not
typically seen in sloughing esophagitis, which seems
to be an acute injury.5,6 Furthermore, the illustra-
tions in these papers do not conform to the changes
in sloughing esophagitis detailed above. However,
in two recent reports of EDS,7,8 covering 12 and
41 patients, the histologic descriptions and pho-
tographs are identical to what was described in the
patient population by Purdy et al.4 In fact, the title
of one of these reports used both names.7 Therefore,
for all practical purposes, as currently defined,
sloughing esophagitis and EDS are the same entity.
Clinical presentation
There is no uniform clinical presentation of EDS.
The presentation can vary from features inciden-
tally found on endoscopy to esophageal symptoms,
such as dysphagia or heartburn.4,7–9 The most dra-
matic presentation described are reports of patients
vomiting casts of mucosa.10,11 In the largest study
to date, which included 41 patients with EDS, the
median age of presentation was 65 years, although
17% were younger than 40 years of age.8 The major-
ity of patients were Caucasian and female. The
most common indication for undergoing upper
endoscopy was for the evaluation of dyspepsia, dys-
phagia, heartburn, and regurgitation. Another case
series of 12 patients (median age 65 years, 92% male,
67% Caucasian, and 34% African American) found
that half of EDS patients underwent endoscopy for
dysphagia or melena, but the gastrointestinal bleed-
ing was not believed to be related.7 Rather, EDS was
found incidentally. A smaller case series from Wal-
ter Reed National Military Medical Center described
five patients (80% female, median age 46 years, 40%
Caucasian, 40% African American) who presented
with dysphagia or reflux symptoms.9
Associations with sloughing esophagitis
Interestingly, an association has been reported
between sloughing esophagitis and autoimmune
dermatologic conditions, namely bullous pem-
phigoid and pemphigus vulgaris.12 However, this is
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Figure 2. It is common for some biopsies to capture the separation between the necrotic superficial and viable lower layers, as in
this view. This separation is what produces the spectacular endoscopic changes (H&E ×100). From Ref. 20.
a rare phenomenon, and pemphigus has been docu-
mented in only six case reports in the literature.11–16
In the retrospective study of 41 EDS patients and the
case series of 12 patients, no cases of pemphigus were
reported.7,8 In the case series of five patients, only
one patient had a history of bullous pemphigoid.9
Concern has been raised regarding the fragility of
the skin and mucosa in patients with pemphigus.17
A Nikolsy sign may be present, which reflects strip-
ping of the mucosa with only passage of the endo-
scope or use of biopsy forceps. However, there are
no reported cases in the literature of esophageal
perforation or hemorrhage in patients with
pemphigus and sloughing esophagitis. With
bullous pemphigoid, esophageal contact has led to
the development of bullae in the mucosa.17–19
An association between some medications and
EDS also exists, particularly medications that can
induce topical injury, such as bisphosphonates, non-
steroidal anti-inflammatory drugs, iron, and potas-
sium. In the study of 41 patients with sloughing
esophagitis, 73% had used psychoactive medica-
tions, with selective serotonin reuptake inhibitors
and selective norepinephrine reuptake inhibitors
being the most commonly used.8 It remains unclear
why such medications would lead to sloughing
esophagitis, and there are no current recommenda-
tions to discontinue such agents in patients found
to have sloughing esophagitis.
Endoscopic appearance
The endoscopic features of sloughing esophagitis
are dramatic and impressive, especially when
encountered for the first time (Fig. 3). There
are several findings on endoscopy reported in the
literature. The appearance may be sheets of partially
sloughed mucosa or crumpled, detached mucosa.
It is more common to observe these findings in the
distal esophagus, and they may extend proximally
to either the middle or proximal esophagus.4 Linear
strips of desquamated mucosal layers may also be
seen. At times, the collection of mucosa may give an
appearance of an exudate and resemble esophageal
candidiasis.8,17 The circular pattern of crumpled
mucosa may occasionally partially resemble
eosinophilic esophagitis, but biopsies would not
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Figure 3. Endoscopic features of two cases in which there are linear breaks with mucosal sloughing, classic features of sloughing
esophagitis. From Ref. 9.
reveal dense eosinophilic infiltrates. The detached
mucosa can easily be peeled with biopsy forceps,
although this is unnecessary. In a recent review arti-
cle, Hart et al.8 proposed three endoscopic criteria
for sloughing esophagitis: strips of sloughed mucosa
measuring greater than 2 cm, normal underlying
mucosa, and lack of ulceration in adjacent tissue.
Management
As the underlying pathogenesis of sloughing
esophagitis is unknown, there is no clear consen-
sus for management of this condition. If it is asso-
ciated with an autoimmune dermatologic condi-
tion, treatment of the underlying disorder may
improve esophageal findings. In patients prescribed
medications known to induce topical esophageal
injury, cessation of these medications or switching
to other agents can be considered, when possible.
Given the desquamated appearance of the mucosa,
acid suppressants are often prescribed as treatment.
Although such agents may not resolve the esophagi-
tis, at the very least, a reduction in acid exposure
may assist in healing the mucosa. It is noteworthy,
however, that, in several of the case series of slough-
ing esophagitis, a proportion of patients were on
proton pump inhibitors (PPIs) at the time of diag-
nosis, raising the possibility that PPIs may not have
a role in the treatment of sloughing esophagitis.8,9
Among patients with sloughing esophagitis in
which follow-up occurred, healing has been doc-
umented in as short as 8 weeks, suggesting that it is
a benign condition. In the case series of five patients,
all improved clinically, and, in the only patient who
had endoscopic follow-up, resolution of the find-
ings was noted. In the case series with 12 patients,
80% (4/5) had resolution on follow-up endoscopy.7
In the retrospective study of 41 patients, 34% had
follow-up, with resolution noted in 86% of patients
after a median of 4 months.
Conclusions
Sloughing esophagitis, or EDS, is an uncommon
condition characterized endoscopically by features
of sloughed-off mucosa and histologically by parak-
eratosis and necrosis. There is no known treat-
ment for sloughing esophagitis; however, its natural
course appears benign, as the majority of patients
experience resolution within a relative short period.
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